THE IMPACT OF PD-1+ INNATE-LIKE CD8+T CELLS ON THE HBSAG REDUCTION IN ACTIVE CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS(T) IDE ANALOGUE THERAPY

被引：0
|
作者：
Jeng, Rachel Wen-Juei [1 ]
Huang, Hsiang-Wei [1 ]
Lin, Chia-Wei [1 ]
Fan, Jian He [1 ]
Liu, Yen-Chun [1 ]
Ku, Wei-Ting [1 ]
Wu, Cheng-Heng [1 ]
Huang, Chien-Hao [2 ]
Lin, Yung-Chang [1 ]
Lin, Chun Yen [1 ]
机构：
[1] Chang Gung Mem Hosp, Linkou Med Ctr, Taoyuan, Taiwan
[2] Chang Gung Univ, Taoyuan, Taiwan
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
996
引用
收藏
页码：S755 / S756
页数：2
相关论文
共 50 条
  • [1] Adherence to nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B
    Manolakopoulos, Spilios
    Goulis, John
    Striki, Athanasia
    Deutsch, Melanie
    Perlepe, Nikoleta
    Triantos, Christos
    Papatheodoridis, George V.
    GASTROENTEROLOGY, 2015, 148 (04) : S1068 - S1068
  • [2] KINETICS OF QUANTITATIVE HBsAg DECLINE IN CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS( T) IDE ANTIVIRAL THERAPY
    Hyun, Yong Gyu
    Fung, Scott K.
    HEPATOLOGY, 2023, 78 : S432 - S433
  • [3] Dynamic change in HBsAg in chronic hepatitis B patients receiving nucleos(t)ide analogues in China
    Shu, Meng
    Teng, Jiaming
    Dong, Sijia
    Zhang, Yongjing
    Qiu, Hong
    Cai, Wei
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 241 - 241
  • [4] Association of nucleos(t)ide analogue therapy with Parkinson disease in chronic hepatitis B patients
    Jihye Lim
    Hyo Young Lee
    Hyunji Sang
    Su Jin Jeong
    Ha Il Kim
    Scientific Reports, 15 (1)
  • [5] Outcome of chronic hepatitis B patients who discontinued nucleos(t)ide analogue therapy
    Yapali, Suna
    Oberhelman, Kelly
    Lok, Anna S.
    HEPATOLOGY, 2014, 60 : 1114A - 1115A
  • [6] Interruption of nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B - a new concept to achieve HBsAg reduction?
    Siederdissen, C. Hoener Zu
    Rinker, F.
    Falk, C. S.
    Filmann, N.
    Maasoumy, B.
    Deterding, K.
    Port, K.
    Herrmann, E.
    Wedemeyer, H.
    Manns, M. P.
    Kraft, A. R.
    Cornberg, M.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 50 - 50
  • [7] Hepatitis B Virus-Specific T Cells as a Biomarker for Discontinuation of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
    Tian, Yongjun
    Ou, Jing-hsiung James
    HEPATOLOGY, 2019, 69 (03) : 1342 - 1344
  • [8] Impact of Nucleos(t)ide Analogue Combination Therapy on the Estimated Glomerular Filtration Rate in Patients With Chronic Hepatitis B
    Qi, Xun
    Wang, Jinyu
    Chen, Liang
    Huang, Yuxian
    Qin, Yanli
    Mao, Richeng
    Zhang, Jiming
    MEDICINE, 2015, 94 (15)
  • [9] HBsAg decline after interrupting nucleos(t)ide analogue therapy in HVeAg-negative chronic hepatitis B
    Siederdissen, C. Hoener zu
    Rinker, F.
    Falk, C. S.
    Filmann, N.
    Maasoumy, B.
    Deterding, K.
    Port, K.
    Mix, C.
    Herrmann, E.
    Wedemeyer, H.
    Manns, M. P.
    Kraft, A. R. M.
    Cornberg, M.
    JOURNAL OF CLINICAL VIROLOGY, 2015, 69 : 233 - 233
  • [10] Effect of Nucleos(t)ide Analogue Therapy on Risk of Intrahepatic Cholangiocarcinoma in Patients With Chronic Hepatitis B
    Lee, Teng-Yu
    Hsu, Yao-Chun
    Yu, Shi-Hang
    Lin, Jaw-Town
    Wu, Ming-Shiang
    Wu, Chun-Ying
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (06) : 947 - +
12345